Skip to content
Screener

Citius Oncology, Inc. CTOR Q1 2025 Annual earnings

Reported May 14, 2025 · Before market open

EPS-$0.11Miss by $0.02
Revenue estimate$5.7M
EPS estimate-$0.09

Next report

Date not yet announced

Financials

Q1 2025

Income statement

See full
Operating income-$6.4M+29.0%
Net income-$6.7M-40.9%
EPS (diluted)-$0.09-28.6%

Balance sheet

See full
Cash & equivalents$112.0-99.7%
Total equity$41.3M+81.7%
Total assets$90.5M+24.6%

Cash flow

See full
Operating cash flow-$1.4M-4,447%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$82.29M—

Returns & leverage

See full
Return on equity-72.1%-219pp
Current ratio0.4×+0.4×

FAQ

When did Citius Oncology, Inc. report Q1 2025 earnings?
Citius Oncology, Inc. (CTOR) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Citius Oncology, Inc.'s Q1 2025 revenue and EPS?
Citius Oncology, Inc. reported eps of $-0.11 for Q1 2025.
Did Citius Oncology, Inc. beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.09 by $0.02.
Where can I find Citius Oncology, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001213900-25-043363) and the 10-K/A periodic report (0001213900-25-007012) directly on SEC EDGAR. The filing index links above go to sec.gov.